FDA Panel Considers HPV Vaccine “Cervarix”

A new drug called Cervarix, which has been shown to be effective at preventing cervical cancer in teens and women up to age 25, is up for the FDA’s consideration. This new drug is not only effective against those two HPV strains, but it also claims to enhance the immune system’s response againsnt those HPV strains.

From WebMD 9/8/2009

Tags: ,